Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 3Nasopharyngeal Carcinoma 2Squamous Cell Carcinoma of Head and Neck 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Gastric Cancer 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 20Surgical Procedures, Operative 9Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 6pembrolizumab 5Specimen Handling 5Radiotherapy 5Fluorouracil 5toripalimab 4Surveys and Questionnaires 4Radiation 4Paclitaxel 4Chemoradiotherapy 4Celecoxib 4X-Rays 3Platinum 3Counseling 3Carboplatin 3130-nm albumin-bound paclitaxel 31,2-diaminocyclohexaneplatinum II citrate 3camrelizumab 2Taxes 2Standard of Care 2Psychiatric Rehabilitation 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Narrow Band Imaging 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypopharyngeal Neoplasms × CF regimen × Clear all
NCT01312350 2019-12-09

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Samsung Medical Center

Phase 2 Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡